Real World Study with Benralizumab in Severe Asthma in Switzerland

Trial Identifier: D3250R00048
Sponsor: AstraZeneca
NCTID:: NCT03907137
Start Date: January 2019
Primary Completion Date: January 2023
Study Completion Date: January 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations